Infectious Disease Testing Market Analysis Focusing on Top Key Players – Abbott Laboratories, Becton, Dickinson and Company etc.

Infectious Disease Testing Market Snapshot:

The infectious disease testing market was valued at USD 16.39 billion in 2019 and is expected to grow with a CAGR of 5.72% during the forecast period of 2020–2029.

Infectious disease testing involves identifying the presence of foreign antigen/organism using testing tools and kits. Currently, most of the testing tools and kits available are for bacterial and viral infections. It is expected that the molecular techniques will replace most of these testing kits in the coming years. Advances in treating viral infections, active participation of the government, and rising demand for new research methods to monitor infectious diseases drive the market growth. HIV testing is the first critical step taken to address the HIV epidemic across the glove. In April 2019, the U.S. Preventive Service Task Force (USPSTF) announced a Broutine HIV screening. The emergence of fourth-generation HIV testing has enabled the identification of HIV infections in the acute phase or ‘window period’. The window period is the time between HIV infection and the detection of HIV antibodies leading to earlier diagnosis and engagement in all stages of care.

The Center for Disease Control and Prevention (CDC) developed a rapid test kit, CDC 2019 Novel Coronavirus (2019-nCov), Real-Time Real Transcriptase (RT-PCR), and Diagnostic Panel (CDC 2019-nCoV Real-Time RT-PCR) for the diagnosis of COVID-19. About 200 test kits were distributed across the U.S. domestic laboratories and international laboratories. The kit is specialized to test approximately 700 to 800 patient specimens.

The rising application of NGS and advancements in sequencing technologies drive market growth. NGS has the potential to accelerate the early detection of disorders and the identification of pharmacogenetic markers to customize the treatment. Library preparation, assay designing, and data analysis are the key phases of entire NGS procedures. On September 12, 2018, the FDA launched the guidelines for NGS-based infectious disease diagnostics.

In the U.S., the New York State Department of Health uses whole-genome sequencing for viral infections such as influenza. Several companies are developing NGS based infectious disease tests in the country, which include Fry Labs, IDbyDNA, and Karius. The FDA is also actively working in the field of NGS, as it holds great potential to improve infectious disease diagnostics.

The hospital/clinical laboratories segment dominates the infectious disease testing market as they are easily accessible, offer quick test results, and provide flexibility in terms of scheduling specimen pickups. Rising population, increasing medicare reimbursement, and the emergence of advanced diagnostic tests drive the segment growth.

North America leads the infectious disease testing market as it possesses leading national clinical laboratories, highly developed healthcare systems, and easy accessibility to technologically advanced equipment. Currently, the clinical laboratories in the region are focussing on the next-generation sequencing technology as a novel development for infectious disease testing. The U.S. has been witnessing a lack of supply for testing kits due to coronavirus.

Obtain Brochure For Latest Technology Advancements @ 
https://straitsresearch.com/report/infectious-disease-testing-market/request-sample

The Major Prominent Players Covered in this Report:
Abbott Laboratories, Becton, Dickinson and Company, Biomérieux SA, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific, & More.

By Product & Services, Kits & reagents, Instruments, Software,
By Technology, Immunodiagnostics, DNA sequencing & NGS, PCR,
By End-User, Hospitals/clinical laboratories, Reference laboratories, Physician offices, Academic/research institutes ,

Growing Domestic Demand and Expanding Pharmaceutical Sector to Drive the Demand for Infectious Disease Testing in the APAC Region
Asia-Pacific region is anticipated to hold the largest market share in the global Infectious Disease Testing market during the forecast period 2020-2029. The growth in this region can be attributed to the presence of emerging economies like India, China, Japan, Vietnam, and Indonesia, which account for the largest share in this region. India is one of the largest producers of Infectious Disease Testing and a major exporter of the product to various countries across the globe. India accounts for around 80% of the world’s exports of Infectious Disease Testing. The favorable climatic conditions and growth of agricultural inputs and allied services like cold storage and warehousing in India are prompting higher production.

View this report with a detailed description and TOC @ 
https://straitsresearch.com/report/infectious-disease-testing-market/toc

Key Questions Answered in The Report:
What will the Infectious Disease Testing market growth rate?
What are the key factors driving the global Infectious Disease Testing market?
Who are the key manufacturers in the Infectious Disease Testing market space?
What are the market opportunities, market risk, and market overview of the Infectious Disease Testing market?
What are sales, revenue, and price analysis of top manufacturers of the Infectious Disease Testing market?
Who are the distributors, traders, and dealers of the Infectious Disease Testing market?
What are the market opportunities and threats faced by the vendors in the global Steerable Medical Devices Industry?
What are sales, revenue, and price analysis by types and applications of the Infectious Disease Testing Industry?
What are sales, revenue, and price analysis by regions of Infectious Disease Testing industry?
What are the driving factors contributing to market growth during the short, medium, and long term?

Key Infectious Disease Testing Market Trends:
- The report identifies, determines, and forecasts the Global Infectious Disease Testing Market segments based on their type, sub-type, technology used, applications, end-users, and regions.
- Industry to Industry Holds Largest Share in the Infectious Disease Testing Market
- It examines the micro-markets based on their growth trends, development patterns, future prospects, and contribution to the overall market.
- Demand from Regional / geographical is Expected to Drive the Growth
- Rising Adoption of Market Segments in this Growth
- North American, Europe is Expected to Witness Higher Growth Rate over the Forecast Period
- It studies the competitive developments such as partnerships and collaborations, mergers and acquisitions (M&A), research and development (R&D) activities, product developments, and expansions in the Global Infectious Disease Testing Market.

Key Developments -
On March 18, 2020, Abbott received emergency use authorization (EUA) from the Food and Drug Administration (FDA) for its molecular test for the identification of SARS-CoV-2, the virus that causes COVID-19. The company will deploy about 150,000 laboratory tests immediately.

On March 31, 2020, Becton Dickinson and Company (BD) announced the launch of a new Rapid Serology Test to detect exposure to COVID-19. The technique is a new point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19 in less than 15 minutes.

The new test developed will be available through BD and distributed exclusively through Henry Schein, Inc. to healthcare providers throughout the U.S.

Browse Full Report @ https://straitsresearch.com/report/infectious-disease-testing-market/

Even if your business is a multinational venture or a single storefront, we believe innovation is the key to progress, in both what you build and how you promote your products and brands.

Buy Full Report with Detail Analysis with COVID-19 Impact – https://straitsresearch.com/buy-now/infectious-disease-testing-market/global/

So let's put our minds together. We'll make your vision a reality and help you grow.

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com/

About Us:
Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enables us to determine greater insights by eliminating the research costs.

This release was published on openPR.